Our findings support the oncogenic role of LINC01116 in promoting the development of doxorubicin resistance in osteosarcoma, and LINC01116/miR-424-5p/HMGA2 axis may be a promising chemo sensitizing strategy for the treatment of osteosarcoma. The gene discussed is HMGA2; the disease is osteosarcoma.